David H. Koch Institute for Integrative Cancer Research feted
MIT celebrates the official opening of the institute's new building.
MIT celebrates the official opening of the institute's new building.
Team identifies potential drugs that enhance stress caused by too many chromosomes.
Implanted device can release slow, steady dose of medicine over extended period, removing the need for repeated procedures.
Biologists find that restoring the gene for p53 can slow the spread of advanced lung tumors, but doesn’t help early-stage cancers.
Completion of cancer-research building opens green space for community use and creates vibrant streetscape.
RNA interference holds much promise as a cancer treatment, but technical challenges remain.
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
Shutting down an enzyme that responds to DNA damage could boost the effects of traditional chemotherapy.
Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse.
Researchers will start moving into the 365,000-square-foot building next week.
New finding that tumor cells in both species have too many chromosomes could help pinpoint genes that drive cancer development.
A cancer-cell quirk could be exploited to develop new drugs that starve tumors.
Drugs encapsulated in new MIT nanoparticles can hitch a ride to tumors on the surface of immune-system cells.
Organizations will collaborate in multiple areas of oncology research and technology development.